Radiation therapy study seeks immune clues for better cancer treatment
NCT ID NCT02439008
First seen Mar 17, 2026 · Last updated May 15, 2026 · Updated 6 times
Summary
This study looked at how the immune system responds during high-dose radiation therapy in people with liver, colorectal, melanoma, or kidney cancers. Researchers collected blood samples before, during, and after treatment to track immune cells and other markers. The goal was to learn more about how radiation affects the immune system, which could help design better combination treatments with immunotherapy. The study was ended early, but the data may still provide useful insights.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Oscar Lambret
Lille, 59020, France
Conditions
Explore the condition pages connected to this study.